Importantly, mutations in p53 are typically associated with a variety of cancers.19 Bleomycin activates the intrinsic apoptotic signaling pathway in response to DNA damage by the p53 class mediator, where an array of intracellular molecular signals is conveyed to trigger apoptosis mediated cell death.19 The gene discussed is TP53; the disease is cancer.